Company
Headquarters: Jakarta, Indonesia
Employees: 12,939
Rp21.205 Trillion
IDR as of Jan. 1, 2026
US$1.27 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2020, it operated 40 hospitals. The company was founded in 1999 and is based in Jakarta, Indonesia.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | Rp6.979 T |
| EBITDA | Rp1.223 T |
| Gross Profit TTM | Rp2.168 T |
| Profit Margin | 6.07% |
| Operating Margin | 14.63% |
| Quarterly Revenue Growth | 12.90% |
PT Medikaloka Hermina Tbk has the following listings and related stock indices.
Stock: IDX: HEAL wb_incandescent